;PMID: 10199577
;source_file_1914.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..35] = [t:0..35]
;1)sentence:[e:41..145] = [t:41..145]
;2)section:[e:149..178] = [t:149..178]
;3)section:[e:182..293] = [t:182..293]
;4)sentence:[e:297..472] = [t:297..472]
;5)sentence:[e:473..771] = [t:473..771]
;6)sentence:[e:772..926] = [t:772..926]
;7)sentence:[e:927..1076] = [t:927..1076]
;8)sentence:[e:1077..1335] = [t:1077..1335]
;9)sentence:[e:1336..1411] = [t:1336..1411]
;10)sentence:[e:1412..1476] = [t:1412..1476]
;11)sentence:[e:1477..1573] = [t:1477..1573]
;12)sentence:[e:1574..1677] = [t:1574..1677]
;13)section:[e:1681..1726] = [t:1681..1726]

;section 0 Span:0..35
;Toxicology. 1999 Jan 1;132(1):9-18.
(SEC
  (FRAG (NNP:[0..10] Toxicology) (.:[10..11] .) (CD:[12..16] 1999)
        (CC:[17..20] Jan) (CD:[21..26] 1;132) (-LRB-:[26..27] -LRB-)
        (CD:[27..28] 1) (-RRB-:[28..29] -RRB-) (::[29..30] :) (CD:[30..32] 9-)
        (CD:[32..34] 18) (.:[34..35] .)))

;sentence 1 Span:41..145
;Trichloroethylene inhibits aldehyde dehydrogenase only for aliphatic
;aldehydes  of short chains in rats.
;[41..58]:substance:"Trichloroethylene"
;[68..90]:substance:"aldehyde dehydrogenase"
;[100..119]:substance:"aliphatic aldehydes"
(SENT
  (S-HLN
    (NP-SBJ (NN:[41..58] Trichloroethylene))
    (VP (VBZ:[59..67] inhibits)
      (NP (NN:[68..76] aldehyde) (NN:[77..90] dehydrogenase))
      (PP (RB:[91..95] only) (IN:[96..99] for)
        (NP
          (NP (JJ:[100..109] aliphatic) (NNS:[110..119] aldehydes))
          (PP (IN:[121..123] of)
            (NP (JJ:[124..129] short) (NNS:[130..136] chains)))))
      (PP-LOC (IN:[137..139] in)
        (NP (NNS:[140..144] rats))))
    (.:[144..145] .)))

;section 2 Span:149..178
;Wang RS, Nakajima T, Honma T.
(SEC
  (FRAG (NNP:[149..153] Wang) (NNP:[154..156] RS) (,:[156..157] ,)
        (NNP:[158..166] Nakajima) (NNP:[167..168] T) (,:[168..169] ,)
        (NNP:[170..175] Honma) (NNP:[176..178] T.)))

;section 3 Span:182..293
;Division of Health Effects Research, National Institute of Industrial Health,
; Kawasaki, Japan. wang@niih.go.jp
(SEC
  (FRAG (NNP:[182..190] Division) (IN:[191..193] of) (NNP:[194..200] Health)
        (NNS:[201..208] Effects) (NNP:[209..217] Research) (,:[217..218] ,)
        (NNP:[219..227] National) (NNP:[228..237] Institute) (IN:[238..240] of)
        (NNP:[241..251] Industrial) (NNP:[252..258] Health) (,:[258..259] ,)
        (NNP:[261..269] Kawasaki) (,:[269..270] ,) (NNP:[271..276] Japan)
        (.:[276..277] .) (``:[278..290] wang@niih.go) (NN:[290..293] .jp)))

;sentence 4 Span:297..472
;The effects of trichloroethylene (TCE) administration on aldehyde
;dehydrogenase  (ALDH) and cytochrome P450 isozymes were studied in rats and
;compared with those  of methanol.
;[312..329]:substance:"trichloroethylene"
;[331..334]:substance:"TCE"
;[354..376]:substance:"aldehyde dehydrogenase"
;[379..383]:substance:"ALDH"
;[389..413]:cyp450:"cytochrome P450 isozymes"
;[463..471]:substance:"methanol"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[297..300] The) (NNS:[301..308] effects))
      (PP (IN:[309..311] of)
        (NP
          (NP
            (NML
              (NML (NN:[312..329] trichloroethylene))
              (NML (-LRB-:[330..331] -LRB-) (NN:[331..334] TCE)
                   (-RRB-:[334..335] -RRB-)))
            (NN:[336..350] administration))
          (PP (IN:[351..353] on)
            (NP
              (NP
                (NP (NN:[354..362] aldehyde) (NN:[363..376] dehydrogenase))
                (NP (-LRB-:[378..379] -LRB-) (NN:[379..383] ALDH)
                    (-RRB-:[383..384] -RRB-)))
              (CC:[385..388] and)
              (NP
                (NML (NN:[389..399] cytochrome) (NN:[400..404] P450))
                (NNS:[405..413] isozymes)))))))
    (VP (VBD:[414..418] were)
      (VP
        (VP (VBN:[419..426] studied)
          (NP-1 (-NONE-:[426..426] *))
          (PP-LOC (IN:[427..429] in)
            (NP-SBJ (NNS:[430..434] rats))))
        (CC:[435..438] and)
        (VP (VBN:[439..447] compared)
          (NP-1 (-NONE-:[447..447] *))
          (-NONE-:[447..447] *P*)
          (PP-CLR (IN:[448..452] with)
            (NP
              (NP (DT:[453..458] those))
              (PP (IN:[460..462] of)
                (NP (NN:[463..471] methanol))))))))
    (.:[471..472] .)))

;sentence 5 Span:473..771
;Intragastric administration of TCE to rats at 0.05 or 0.2 ml/kg for  1 week
;significantly inhibited ALDH activity for aliphatic aldehydes of short 
;chains in the mitochondrial and cytosolic fractions of rat liver,
;respectively,  but had no effect on the activity for long chain aliphatic
;aldehydes.
;[504..507]:substance:"TCE"
;[519..523]:quantitative-value:"0.05"
;[527..530]:quantitative-value:"0.2"
;[531..536]:quantitative-units:"ml/kg"
;[542..543]:quantitative-value:"1"
;[544..548]:quantitative-units:"week"
;[573..577]:substance:"ALDH"
;[591..610]:substance:"aliphatic aldehydes"
;[740..770]:substance:"long chain aliphatic aldehydes"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[473..485] Intragastric) (NN:[486..500] administration))
      (PP (IN:[501..503] of)
        (NP (NN:[504..507] TCE)))
      (PP (TO:[508..510] to)
        (NP (NNS:[511..515] rats)))
      (PP (IN:[516..518] at)
        (NP
          (NP
            (NP (CD:[519..523] 0.05)
              (NML-2 (-NONE-:[523..523] *P*)))
            (PP-3 (-NONE-:[523..523] *P*)))
          (CC:[524..526] or)
          (NP
            (NP (CD:[527..530] 0.2)
              (NML-2 (NN:[531..533] ml)))
            (PP-3 (SYM:[533..534] /)
              (NP (NN:[534..536] kg))))))
      (PP-TMP (IN:[537..540] for)
        (NP (CD:[542..543] 1) (NN:[544..548] week))))
    (VP
      (VP
        (ADVP (RB:[549..562] significantly))
        (VBD:[563..572] inhibited)
        (NP (NN:[573..577] ALDH) (NN:[578..586] activity))
        (PP (IN:[587..590] for)
          (NP
            (NP (JJ:[591..600] aliphatic) (NNS:[601..610] aldehydes))
            (PP (IN:[611..613] of)
              (NP (JJ:[614..619] short) (NNS:[621..627] chains)))))
        (PP (IN:[628..630] in)
          (NP
            (NP (DT:[631..634] the)
              (NML
                (NML (JJ:[635..648] mitochondrial)
                  (NML-1 (-NONE-:[648..648] *P*)))
                (CC:[649..652] and)
                (NML (JJ:[653..662] cytosolic)
                  (NML-1 (NNS:[663..672] fractions)))))
            (PP (IN:[673..675] of)
              (NP (NN:[676..679] rat) (NN:[680..685] liver)))
            (,:[685..686] ,)
            (ADVP (RB:[687..699] respectively)))))
      (,:[699..700] ,) (CC:[702..705] but)
      (VP (VBD:[706..709] had)
        (NP
          (NP (DT:[710..712] no) (NN:[713..719] effect))
          (PP (IN:[720..722] on)
            (NP (DT:[723..726] the) (NN:[727..735] activity)))
          (PP (IN:[736..739] for)
            (NP
              (NML (JJ:[740..744] long) (NN:[745..750] chain))
              (JJ:[751..760] aliphatic) (NNS:[761..770] aldehydes))))))
    (.:[770..771] .)))

;sentence 6 Span:772..926
;ALDH  activity catalyzing the metabolism of some aromatic aldehydes was even
;induced  by TCE. Microsomal ALDH activity was not decreased by TCE
;treatment.
;[772..776]:substance:"ALDH"
;[821..839]:substance:"aromatic aldehydes"
;[861..864]:substance:"TCE"
;[877..881]:substance:"ALDH"
;[912..915]:substance:"TCE"
(SENT
  (S
    (NP-SBJ-2
      (NP (NN:[772..776] ALDH) (NN:[778..786] activity))
      (VP (VBG:[787..797] catalyzing)
        (NP
          (NP (DT:[798..801] the) (NN:[802..812] metabolism))
          (PP (IN:[813..815] of)
            (NP (DT:[816..820] some)
               (JJ:[821..829] aromatic) (NNS:[830..839] aldehydes))))))
    (VP (VBD:[840..843] was)
      (ADVP (RB:[844..848] even))
      (VP (VBN:[849..856] induced)
        (NP-2 (-NONE-:[856..856] *))
        (PP (IN:[858..860] by)
          (NP-LGS (NN:[861..864] TCE)))))
    (.:[864..865] .))
  (S
    (NP-SBJ-1 (JJ:[866..876] Microsomal) (NN:[877..881] ALDH)
              (NN:[882..890] activity))
    (VP (VBD:[891..894] was) (RB:[895..898] not)
      (VP (VBN:[899..908] decreased)
        (NP-1 (-NONE-:[908..908] *))
        (PP (IN:[909..911] by)
          (NP-LGS (NN:[912..915] TCE) (NN:[916..925] treatment)))))
    (.:[925..926] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[772..926]::S:S:

;sentence 7 Span:927..1076
;A kinetic  study showed that the low-Km isozyme of ALDH for propionaldehyde
;in  mitochondrial and cytosolic fractions was inhibited by TCE treatment.
;[964..966]:quantitative-name:"Km"
;[967..974]:substance:"isozyme"
;[978..982]:substance:"ALDH"
;[987..1002]:substance:"propionaldehyde"
;[1062..1065]:substance:"TCE"
(SENT
  (S
    (NP-SBJ (DT:[927..928] A) (JJ:[929..936] kinetic) (NN:[938..943] study))
    (VP (VBD:[944..950] showed)
      (SBAR (IN:[951..955] that)
        (S
          (NP-SBJ-2
            (NP (DT:[956..959] the)
              (NML (JJ:[960..963] low) (HYPH:[963..964] -) (NN:[964..966] Km))
              (NN:[967..974] isozyme))
            (PP (IN:[975..977] of)
              (NP (NN:[978..982] ALDH)))
            (PP (IN:[983..986] for)
              (NP (NN:[987..1002] propionaldehyde)))
            (PP-LOC (IN:[1003..1005] in)
              (NP
                (NP (JJ:[1007..1020] mitochondrial)
                  (NML-1 (-NONE-:[1020..1020] *P*)))
                (CC:[1021..1024] and)
                (NP (JJ:[1025..1034] cytosolic)
                  (NML-1 (NNS:[1035..1044] fractions))))))
          (VP (VBD:[1045..1048] was)
            (VP (VBN:[1049..1058] inhibited)
              (NP-2 (-NONE-:[1058..1058] *))
              (PP (IN:[1059..1061] by)
                (NP-LGS (NN:[1062..1065] TCE) (NN:[1066..1075] treatment))))))))
    (.:[1075..1076] .)))

;sentence 8 Span:1077..1335
;Addition  of TCE, trichloroethanol or trichloroacetic acid to the in vitro
;assay system  did not affect the activity for acetaldehyde, but chloral
;hydrate at 0.02 mM  decreased the activity by 42 and 35% in cytosol and the
;700 x g supernatant,  respectively.
;[1090..1094]:substance:"TCE,"
;[1095..1111]:substance:"trichloroethanol"
;[1115..1135]:substance:"trichloroacetic acid"
;[1198..1210]:substance:"acetaldehyde"
;[1216..1231]:substance:"chloral hydrate"
;[1235..1239]:quantitative-value:"0.02"
;[1240..1242]:quantitative-units:"mM"
;[1270..1272]...[1279..1280]:quantitative-value:"42"..."%"
;[1277..1280]:quantitative-value:"35%"
;[1300..1305]:quantitative-value:"700 x"
;[1306..1307]:quantitative-units:"g"
(SENT
  (S
    (S
      (NP-SBJ
        (NP (NN:[1077..1085] Addition))
        (PP (IN:[1087..1089] of)
          (NP
            
            (NP (NN:[1090..1093] TCE))
            (,:[1093..1094] ,)
            (NP (NN:[1095..1111] trichloroethanol))
            (CC:[1112..1114] or)
            (NP (JJ:[1115..1130] trichloroacetic) (NN:[1131..1135] acid))))
        (PP (TO:[1136..1138] to)
          (NP (DT:[1139..1142] the)
            (ADJP (FW:[1143..1145] in) (FW:[1146..1151] vitro))
            (NN:[1152..1157] assay) (NN:[1158..1164] system))))
      (VP (VBD:[1166..1169] did) (RB:[1170..1173] not)
        (VP (VB:[1174..1180] affect)
          (NP (DT:[1181..1184] the) (NN:[1185..1193] activity))
          (PP (IN:[1194..1197] for)
            (NP (NN:[1198..1210] acetaldehyde))))))
    (,:[1210..1211] ,) (CC:[1212..1215] but)
    (S
      (NP-SBJ
        (NP (JJ:[1216..1223] chloral) (NN:[1224..1231] hydrate))
        (PP (IN:[1232..1234] at)
          (NP (CD:[1235..1239] 0.02) (NN:[1240..1242] mM))))
      (VP (VBD:[1244..1253] decreased)
        (NP (DT:[1254..1257] the) (NN:[1258..1266] activity))
        (PP (IN:[1267..1269] by)
          (NP-EXT
            (NP (CD:[1270..1272] 42)
              (NML-1 (-NONE-:[1272..1272] *P*)))
            (CC:[1273..1276] and)
            (NP (CD:[1277..1279] 35)
              (NML-1 (NN:[1279..1280] %)))))
        (PP-LOC (IN:[1281..1283] in)
          (NP
            (NP (NN:[1284..1291] cytosol))
            (CC:[1292..1295] and)
            (NP (DT:[1296..1299] the)
              (NML
                 (CD:[1300..1303] 700) (SYM:[1304..1305] x)
                (NN:[1306..1307] g))
              (NN:[1308..1319] supernatant))))
        (,:[1319..1320] ,)
        (ADVP (RB:[1322..1334] respectively))))
    (.:[1334..1335] .)))

;sentence 9 Span:1336..1411
;Methanol treatment, on the other hand, had no effect on any ALDH  activity.
;[1336..1344]:substance:"Methanol"
;[1396..1400]:substance:"ALDH"
(SENT
  (S
    (NP-SBJ (NN:[1336..1344] Methanol) (NN:[1345..1354] treatment))
    (,:[1354..1355] ,)
    (PP (IN:[1356..1358] on)
      (NP (DT:[1359..1362] the) (JJ:[1363..1368] other) (NN:[1369..1373] hand)))
    (VP (,:[1373..1374] ,) (VBD:[1375..1378] had)
      (NP (DT:[1379..1381] no) (NN:[1382..1388] effect))
      (PP (IN:[1389..1391] on)
        (NP (DT:[1392..1395] any) (NN:[1396..1400] ALDH)
            (NN:[1402..1410] activity))))
    (.:[1410..1411] .)))

;sentence 10 Span:1412..1476
;Both TCE and methanol significantly induced CYP2E1 in rat liver.
;[1417..1420]:substance:"TCE"
;[1425..1433]:substance:"methanol"
;[1456..1462]:cyp450:"CYP2E1"
(SENT
  (S
    (NP-SBJ (CC:[1412..1416] Both)
      (NML (NN:[1417..1420] TCE) (CC:[1421..1424] and)
           (NN:[1425..1433] methanol)))
    (ADVP (RB:[1434..1447] significantly))
    (VP (VBD:[1448..1455] induced)
      (NP (NN:[1456..1462] CYP2E1))
      (PP-LOC (IN:[1463..1465] in)
        (NP (NN:[1466..1469] rat) (NN:[1470..1475] liver))))
    (.:[1475..1476] .)))

;sentence 11 Span:1477..1573
;The  combined effects of TCE on ALDH and cytochrome P450 may account for the 
;degreasers' flush.
;[1502..1505]:substance:"TCE"
;[1509..1513]:substance:"ALDH"
;[1518..1533]:cyp450:"cytochrome P450"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1477..1480] The) (VBN:[1482..1490] combined)
          (NNS:[1491..1498] effects))
      (PP (IN:[1499..1501] of)
        (NP (NN:[1502..1505] TCE)))
      (PP (IN:[1506..1508] on)
        (NP
          (NP (NN:[1509..1513] ALDH))
          (CC:[1514..1517] and)
          (NP (NN:[1518..1528] cytochrome) (NN:[1529..1533] P450)))))
    (VP (MD:[1534..1537] may)
      (VP (VB:[1538..1545] account)
        (PP-CLR (IN:[1546..1549] for)
          (NP
            (NP (DT:[1550..1553] the) (NNS:[1555..1565] degreasers)
                (POS:[1565..1566] '))
            (NN:[1567..1572] flush)))))
    (.:[1572..1573] .)))

;sentence 12 Span:1574..1677
;Exposure to TCE and methanol may result in a change in the  metabolism and
;toxicity of other chemicals.
;[1586..1589]:substance:"TCE"
;[1594..1602]:substance:"methanol"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1574..1582] Exposure))
      (PP (TO:[1583..1585] to)
        (NP (NN:[1586..1589] TCE) (CC:[1590..1593] and)
            (NN:[1594..1602] methanol))))
    (VP (MD:[1603..1606] may)
      (VP (VB:[1607..1613] result)
        (PP-CLR (IN:[1614..1616] in)
          (NP (DT:[1617..1618] a) (NN:[1619..1625] change)))
        (PP (IN:[1626..1628] in)
          (NP
            (NP (DT:[1629..1632] the) (NN:[1634..1644] metabolism)
                (CC:[1645..1648] and) (NN:[1649..1657] toxicity))
            (PP (IN:[1658..1660] of)
              (NP (JJ:[1661..1666] other) (NNS:[1667..1676] chemicals)))))))
    (.:[1676..1677] .)))

;section 13 Span:1681..1726
;PMID: 10199577 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1681..1685] PMID) (::[1685..1686] :) (CD:[1687..1695] 10199577)
        (NN:[1696..1697] -LSB-) (NNP:[1697..1703] PubMed) (::[1704..1705] -)
        (NN:[1706..1713] indexed) (IN:[1714..1717] for)
        (NNP:[1718..1726] MEDLINE-RSB-)))
